| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.006 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.076 | 0.006 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.007 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.007 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.09 | 0.008 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.096 | 0.008 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.008 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.009 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.009 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.009 |